Neoadjuvant Therapy in Resectable Pancreatic Cancer: Immortal Time Bias and Its Correction

J Clin Oncol. 2017 May 10;35(14):1623. doi: 10.1200/JCO.2016.71.2273. Epub 2017 Jan 30.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bias
  • Humans
  • Neoadjuvant Therapy*
  • Pancreatic Neoplasms*
  • Propensity Score